Subjective and Objective Outcome of ESS in CRSwNP
Launched by UNIVERSITY OF ZURICH · Apr 27, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two types of surgical procedures for patients suffering from chronic rhinosinusitis with nasal polyps (CRSwNP) who have not found relief from medication or other treatments for at least six months. The surgeries being tested are designed to improve access to the sinuses and remove blockages, which can help reduce symptoms like nasal congestion and difficulty breathing.
To participate in this trial, you need to be between 18 and 65 years old, have a specific level of sinus disease, and have not had previous sinus surgery. If you join, you can expect to undergo one of the surgical procedures and be monitored afterwards to see how well it works for you. This study is currently recruiting participants, and your involvement could help improve treatment options for others with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Symptomatic CRSwNP patients without improvement after conservative treatment for at least 6 months Extent of disease at least Davos Polyp Score ≥ 4 points Age 18-65 years Signed consent
- Exclusion Criteria:
- • Previous sinunasal surgery High resolution paranasal sinus CT shows other pathology (e.g. mucocele) Incapable of judgement
About University Of Zurich
The University of Zurich, a leading institution in research and education, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust framework for conducting high-quality research, the university collaborates with multidisciplinary teams of experts to explore cutting-edge therapeutic approaches and interventions. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the utmost integrity, aiming to contribute valuable insights to the medical community and enhance health outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials